PL3189045T3 - Nowe sole nilotynibu i jego polimorfy - Google Patents

Nowe sole nilotynibu i jego polimorfy

Info

Publication number
PL3189045T3
PL3189045T3 PL15832018T PL15832018T PL3189045T3 PL 3189045 T3 PL3189045 T3 PL 3189045T3 PL 15832018 T PL15832018 T PL 15832018T PL 15832018 T PL15832018 T PL 15832018T PL 3189045 T3 PL3189045 T3 PL 3189045T3
Authority
PL
Poland
Prior art keywords
nilotinib
polymorphs
novel salts
salts
novel
Prior art date
Application number
PL15832018T
Other languages
English (en)
Inventor
Rajamannar Thennati
Srinivasu Kilaru
Macwan VALANCE SURENDRAKUMAR
Dwivedi SHRIPRAKASH DHAR
Original Assignee
Sun Pharmaceutical Industries Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sun Pharmaceutical Industries Limited filed Critical Sun Pharmaceutical Industries Limited
Publication of PL3189045T3 publication Critical patent/PL3189045T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL15832018T 2014-08-11 2015-08-10 Nowe sole nilotynibu i jego polimorfy PL3189045T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
IN2583MU2014 2014-08-11
PCT/IN2015/050086 WO2016024289A2 (en) 2014-08-11 2015-08-10 Novel salts of nilotinib and polymorphs thereof
EP15832018.4A EP3189045B1 (en) 2014-08-11 2015-08-10 Novel salts of nilotinib and polymorphs thereof

Publications (1)

Publication Number Publication Date
PL3189045T3 true PL3189045T3 (pl) 2022-04-04

Family

ID=55304722

Family Applications (1)

Application Number Title Priority Date Filing Date
PL15832018T PL3189045T3 (pl) 2014-08-11 2015-08-10 Nowe sole nilotynibu i jego polimorfy

Country Status (14)

Country Link
US (1) US10138221B2 (pl)
EP (1) EP3189045B1 (pl)
CY (1) CY1125143T1 (pl)
DK (1) DK3189045T3 (pl)
ES (1) ES2908457T3 (pl)
HR (1) HRP20220358T1 (pl)
HU (1) HUE058726T2 (pl)
LT (1) LT3189045T (pl)
PL (1) PL3189045T3 (pl)
PT (1) PT3189045T (pl)
RS (1) RS63029B1 (pl)
SI (1) SI3189045T1 (pl)
SM (1) SMT202200119T1 (pl)
WO (1) WO2016024289A2 (pl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3429589B1 (en) 2016-03-17 2022-12-14 Sun Pharmaceutical Industries Ltd Pharmaceutical composition of nilotinib
EP3404025B1 (en) * 2017-05-16 2019-12-04 F.I.S.- Fabbrica Italiana Sintetici S.p.A. Process for the preparation of pure nilotinib and its salt
CN113292537B (zh) 2018-06-15 2024-04-05 汉达癌症医药责任有限公司 激酶抑制剂的盐类及其组合物
SG11202100240RA (en) * 2018-07-18 2021-02-25 Astrazeneca Ab A xinafoate salt of a jak inhibiting compound
US20230075170A1 (en) 2020-02-15 2023-03-09 Cipla Limited Novel salts of nilotinib and polymorphic forms thereof

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4938206B2 (ja) 2001-04-06 2012-05-23 チバ ホールディング インコーポレーテッド ポリマー上へグラフト化されたスルホキシド又はスルホン
US6479692B1 (en) * 2001-05-02 2002-11-12 Nobex Corporation Methods of synthesizing acylanilides including bicalutamide and derivatives thereof
JP2007023062A (ja) 2005-07-12 2007-02-01 Jsr Corp 熱可塑性エラストマー組成物、その成形品の接着方法、その成形品を含む複合成形品及びその複合成形品を備える医療用輸液セット
GT200600316A (es) * 2005-07-20 2007-04-02 Sales de 4-metilo-n-(3-(4-metilo-imidazol-1-ilo)-5-trifluorometilo-fenilo)-3-(4-piridina-3-ilo-pirimidina-2-iloamino)- benzamida.
EP1923053A1 (en) * 2006-09-27 2008-05-21 Novartis AG Pharmaceutical compositions comprising nilotinib or its salt
US7715251B2 (en) 2006-10-25 2010-05-11 Hewlett-Packard Development Company, L.P. Memory access strobe configuration system and process
US8350204B2 (en) 2007-12-12 2013-01-08 Mark Moser Light source tracker
JP4433093B2 (ja) 2008-05-09 2010-03-17 ダイキン工業株式会社 クロスフローファン及びこれを備えた空気調和機
JP2011086428A (ja) 2009-10-14 2011-04-28 I-Pex Co Ltd コネクタ装置
WO2012070062A2 (en) * 2010-11-26 2012-05-31 Hetero Research Foundation Novel polymorph of nilotinib hydrochloride
US20140059518A1 (en) 2012-08-24 2014-02-27 Velocio Networks, Inc. Method for Object Oriented Programming of Programmable Logic Controllers in Graphical Programming Languages
CN103864756B (zh) * 2012-12-11 2018-06-15 四川海思科制药有限公司 丁二磺酸达比加群酯及其制备方法和用途
CN104644543A (zh) * 2014-12-25 2015-05-27 青岛黄海制药有限责任公司 一种含达比加群酯的固体分散体及其制备和应用

Also Published As

Publication number Publication date
HRP20220358T1 (hr) 2022-05-13
EP3189045A4 (en) 2018-02-14
SI3189045T1 (sl) 2022-05-31
CY1125143T1 (el) 2023-06-09
HUE058726T2 (hu) 2022-09-28
WO2016024289A3 (en) 2016-09-15
US20170233372A1 (en) 2017-08-17
US10138221B2 (en) 2018-11-27
ES2908457T3 (es) 2022-04-29
SMT202200119T1 (it) 2022-05-12
EP3189045B1 (en) 2022-02-09
RS63029B1 (sr) 2022-04-29
PT3189045T (pt) 2022-03-17
WO2016024289A2 (en) 2016-02-18
EP3189045A2 (en) 2017-07-12
DK3189045T3 (da) 2022-03-21
LT3189045T (lt) 2022-04-11

Similar Documents

Publication Publication Date Title
SG11201803408PA (en) Valbenazine salts and polymorphs thereof
ZA201700880B (en) Polymorphs of selinexor
SI3524234T1 (sl) Trdne oblike sofosbuvira
PT3113773T (pt) Formas cristalinas do grapiprant
IL246979A0 (en) Crystalline forms of sofosbuvir
EP3107540A4 (en) Polymorphs of lomitapide and its salts
SMT202200202T1 (it) Sali e polimorfi innovativi di scy-078
PL3189045T3 (pl) Nowe sole nilotynibu i jego polimorfy
ZA201606450B (en) Compounds and their methods of use
HUS2500045I1 (hu) Etilén-glikolok MMF származékai
IL265180B (en) New polymorphs and new solid states of tiacomycin b
SG11201609739UA (en) Derivatives of dolaproine-dolaisoleuine peptides
IL246569A0 (en) Solid forms of tenofovir
ZA201701973B (en) Process for the preparation of halo-substituted trifluoroacetophenones
IL249130B (en) Preparation of piperidine-4-carbothioamide
GB201412010D0 (en) Treatment of hypertransaminasemia
HUP1500506A2 (en) Salts of palbociclib
SG11201708527RA (en) Manufacture of organopolysulfides and salts thereof
IL249332A0 (en) Crystalline forms of sofosbuvir
GB201418230D0 (en) Construction of surfaces
GB201412359D0 (en) Composition of objects
GB201412089D0 (en) Composition of objects
GB201416951D0 (en) Method of synthesis